National Cancer Institute; Notice of Closed Meetings, 4052-4053 [2012-1690]

Download as PDF 4052 Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices Bethesda, MD 20817, (301) 594–5019, charles.rafferty@nih.gov. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases, Special Emphasis Panel, P50 Centers of Research Translation Review. Date: March 8–9, 2012. Time: 8 a.m. to 5 p.m. Agenda : To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Kan Ma, Ph.D., Scientific Review Officer, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, 6701 Democracy Boulevard, Suite 800, Bethesda, MD 20817, (301) 451–4838, mak2@mail.nih. gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: January 19, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/irg/irg.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 19, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–1678 Filed 1–25–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2012–1682 Filed 1–25–12; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P National Center for Complementary & Alternative Medicine; Amended Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee I—Career Development. Date: February 21, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314. Contact Person: Sergei Radaev, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8113, Bethesda, MD 20892, (301) 435–5655, sradaev@mail.nih.gov. VerDate Mar<15>2010 17:14 Jan 25, 2012 Jkt 226001 Notice is hereby given of a change in the meeting of the National Advisory Council for Complementary and Alternative Medicine, February 3, 2012, 8:30 a.m. to February 3, 2012, 4 p.m., National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD, 20892 which was published in the Federal Register on December 21, 2011, 76 FR 79202. This meeting has been amended so that the open session will begin at 10 a.m. instead of 10:45 am. The public comment period will be from 3:30 p.m. to 3:45 p.m. The meeting is partially Closed to the public. Dated: January 20, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–1702 Filed 1–25–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Topics in Bioengineering Sciences and Technologies. Date: February 9–10, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Joseph D Mosca, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5158, MSC 7808, Bethesda, MD 20892, (301) 435– 2344, moscajos@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 20, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–1699 Filed 1–25–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Review of P01 Grant Applications (SEP One). E:\FR\FM\26JAN1.SGM 26JAN1 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices Date: February 2–3, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Delia Tang, MD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8123, Bethesda, MD 20892, (301) 496–2330, tangd@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to scheduling conflicts. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI SPORE in Breast, Endometrial, and Skin Cancers. Date: February 8–9, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: David G. Ransom, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8133, Bethesda, MD 20892–8328, (301) 451–4757, david. ransom@nih.gov. This notice is being published less than 15 days prior to the meeting due to scheduling conflicts. Name of Committee: National Cancer Institute Special Emphasis Panel, Review of P01 Grant Applications (SEP Four). Date: February 13–14, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC/Rockville Hotel & Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Olivia Bartlett, Ph.D., Chief, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8121, Bethesda, MD 20892–7405, 301/ 594–2501, op2t@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Development of Algorithms for Analysis of In Vivo Images. Date: February 29, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6101 Executive Boulevard, Room 707, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review Officer, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8050A, MSC 8329, Bethesda, MD 20852, zouzhiq@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Simplified Tissue Microarray Instrument for Clinical and Research Settings. Date: March 1, 2012. Time: 12:30 p.m. to 5 p.m. Agenda: To review and evaluate contract proposals. VerDate Mar<15>2010 17:14 Jan 25, 2012 Jkt 226001 Place: National Institutes of Health, 6116 Executive Blvd., Room 607, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Donald L. Coppock, Ph.D., Scientific Review Officer, Scientifc Review and Logistic Branch, Division of Extramural Activities, NCI, National Institutes of Health, 6116 Executive Blvd., Rm 7151, Bethesda, MD 20892, (301) 451–9385, donald. coppock@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Generation and Qualification of Site-Specific PostTranslationally Modified Proteins for use as Calibrators in Pharmacodynamic (PD) Assays (Topic-312). Date: March 7, 2012. Time: 12:15 p.m. to 3:15 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Room 707, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Marvin L. Salin, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, (301) 496–0694, msalin@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, The Role of Microbial Metabolites in Cancer Prevention and Etiology. Date: March 14, 2012. Time: 12 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Blvd., Room 607, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Donald L. Coppock, Ph.D., Scientific Review Officer, Scientifc Review and Logistic Branch, Division of Extramural Activities, NCI, National Institutes of Health, 6116 Executive Blvd., Rm 7151, Bethesda, MD 20892, (301) 451–9385, donald. coppock@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Automated Collection, Storage, Analysis, and Reporting Systems for Dietary Images (Topic-308). Date: March 15, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Viatcheslav A Soldatenkov, M.D., Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd. Room 8057, Bethesda, MD 20892–8329, (301) 451– 4758, soldatenkovv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Companion Diagnostics. Date: March 20–21, 2012. Time: 8 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Jeannette F Korczak, Ph.D., Scientific Review Officer, Resources And PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 4053 Training Review Branch, Division Of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8115, Bethesda, MD 20892, (301) 496–9767, korczakj@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Alliance of Glycobiologists for Detection of Cancer (U01). Date: March 22, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel and Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Marvin L. Salin, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, (301) 496–0694, msalin@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Development of Radiation Modulators for use during Radiotherapy, (Topic-291). Date: March 27–28, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Viatcheslav A Soldatenkov, M.D., Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd. Room 8057, Bethesda, MD 20892–8329, (301) 451– 4758, soldatenkovv@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 19, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–1690 Filed 1–25–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Agency Information Collection Activities: Post-Award Contract Information Office of Chief Procurement Officer, DHS. AGENCY: E:\FR\FM\26JAN1.SGM 26JAN1

Agencies

[Federal Register Volume 77, Number 17 (Thursday, January 26, 2012)]
[Notices]
[Pages 4052-4053]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1690]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Review of P01 Grant Applications (SEP One).

[[Page 4053]]

    Date: February 2-3, 2012.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Delia Tang, MD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Blvd., Room 8123, 
Bethesda, MD 20892, (301) 496-2330, tangd@mail.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI SPORE in Breast, Endometrial, and Skin Cancers.
    Date: February 8-9, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: David G. Ransom, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 
8133, Bethesda, MD 20892-8328, (301) 451-4757, david.ransom@nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Review of P01 Grant Applications (SEP Four).
    Date: February 13-14, 2012.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville Hotel & Executive Meeting 
Center, 1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: Olivia Bartlett, Ph.D., Chief, Research Programs 
Review Branch, Division of Extramural Activities, National Cancer 
Institute, NIH, 6116 Executive Blvd., Room 8121, Bethesda, MD 20892-
7405, 301/594-2501, op2t@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Development of Algorithms for Analysis of In Vivo Images.
    Date: February 29, 2012.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Room 707, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review 
Officer, National Cancer Institute, National Institutes of Health, 
6116 Executive Blvd., Room 8050A, MSC 8329, Bethesda, MD 20852, 
zouzhiq@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Simplified Tissue Microarray Instrument for Clinical and 
Research Settings.
    Date: March 1, 2012.
    Time: 12:30 p.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Blvd., Room 
607, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Donald L. Coppock, Ph.D., Scientific Review 
Officer, Scientifc Review and Logistic Branch, Division of 
Extramural Activities, NCI, National Institutes of Health, 6116 
Executive Blvd., Rm 7151, Bethesda, MD 20892, (301) 451-9385, 
donald.coppock@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Generation and Qualification of Site-Specific Post-
Translationally Modified Proteins for use as Calibrators in 
Pharmacodynamic (PD) Assays (Topic-312).
    Date: March 7, 2012.
    Time: 12:15 p.m. to 3:15 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 707, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Marvin L. Salin, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329, (301) 496-0694, 
msalin@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, The Role of Microbial Metabolites in Cancer Prevention and 
Etiology.
    Date: March 14, 2012.
    Time: 12 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Blvd., Room 
607, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Donald L. Coppock, Ph.D., Scientific Review 
Officer, Scientifc Review and Logistic Branch, Division of 
Extramural Activities, NCI, National Institutes of Health, 6116 
Executive Blvd., Rm 7151, Bethesda, MD 20892, (301) 451-9385, 
donald.coppock@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Automated Collection, Storage, Analysis, and Reporting 
Systems for Dietary Images (Topic-308).
    Date: March 15, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Viatcheslav A Soldatenkov, M.D., Ph.D., 
Scientific Review Officer, Special Review and Logistics Branch, 
Division of Extramural Activities, National Cancer Institute, 6116 
Executive Blvd. Room 8057, Bethesda, MD 20892-8329, (301) 451-4758, 
soldatenkovv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Companion Diagnostics.
    Date: March 20-21, 2012.
    Time: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Jeannette F Korczak, Ph.D., Scientific Review 
Officer, Resources And Training Review Branch, Division Of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8115, Bethesda, MD 20892, (301) 496-9767, 
korczakj@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Alliance of Glycobiologists for Detection of Cancer (U01).
    Date: March 22, 2012.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Lorien Hotel and Spa, 1600 King Street, Alexandria, VA 
22314.
    Contact Person: Marvin L. Salin, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329, (301) 496-0694, 
msalin@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Development of Radiation Modulators for use during 
Radiotherapy, (Topic-291).
    Date: March 27-28, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Viatcheslav A Soldatenkov, M.D., Ph.D., 
Scientific Review Officer, Special Review and Logistics Branch, 
Division of Extramural Activities, National Cancer Institute, 6116 
Executive Blvd. Room 8057, Bethesda, MD 20892-8329, (301) 451-4758, 
soldatenkovv@mail.nih.gov.

    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: January 19, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-1690 Filed 1-25-12; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.